ArticleBritish journal of cancer2009
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
O Bratt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it